Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Discover the detailed record of transactions filed by Mutz Christopher, Responsable. Officer active across 1 company, notably ANI Pharmaceuticals INC. Aggregated, 33 filings have been published. Breakdown: 0 buy · 11 sells. Total volume traded: €2.5m. History available since 15 February 2022. The latest transaction was filed on 13 March 2026 (Cession). Regulator: SEC (Form 4). The full history is openly available.
Companies and markets linked to Mutz Christopher
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Mutz Christopher is a Responsable at ANI Pharmaceuticals INC, where the listed role is HEAD OF RARE DISEASE. He has 33 filings in total. Across the 33 sampled filings, sales total EUR 2533961 and the period runs from 2022-02-17 to 2026-03-13, with transactions of the nature tax withholding.